These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 28130634)

  • 1. X-linked hypophosphatemia and growth.
    Fuente R; Gil-Peña H; Claramunt-Taberner D; Hernández O; Fernández-Iglesias A; Alonso-Durán L; Rodríguez-Rubio E; Santos F
    Rev Endocr Metab Disord; 2017 Mar; 18(1):107-115. PubMed ID: 28130634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypophosphatemia and growth.
    Santos F; Fuente R; Mejia N; Mantecon L; Gil-Peña H; Ordoñez FA
    Pediatr Nephrol; 2013 Apr; 28(4):595-603. PubMed ID: 23179196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.
    Liu ES; Martins JS; Raimann A; Chae BT; Brooks DJ; Jorgetti V; Bouxsein ML; Demay MB
    J Bone Miner Res; 2016 May; 31(5):929-39. PubMed ID: 26751835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Growth Plate Maturation in XLH Is due to Both Excess FGF23 and Decreased 1,25-Dihydroxyvitamin D Signaling.
    Yadav PS; Kobelski MM; Martins JS; Tao T; Liu ES; Demay MB
    Endocrinology; 2023 Nov; 165(1):. PubMed ID: 38066669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
    Kinoshita Y; Fukumoto S
    Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
    Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eldecalcitol Causes FGF23 Resistance for Pi Reabsorption and Improves Rachitic Bone Phenotypes in the Male Hyp Mouse.
    Kaneko I; Segawa H; Ikuta K; Hanazaki A; Fujii T; Tatsumi S; Kido S; Hasegawa T; Amizuka N; Saito H; Miyamoto KI
    Endocrinology; 2018 Jul; 159(7):2741-2758. PubMed ID: 29878089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expanding family of hypophosphatemic syndromes.
    Carpenter TO
    J Bone Miner Metab; 2012 Jan; 30(1):1-9. PubMed ID: 22167381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations.
    Imel EA; DiMeglio LA; Hui SL; Carpenter TO; Econs MJ
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1846-50. PubMed ID: 20157195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 Patients.
    Su PH; Yu JS; Wu YZ; Tsai YS; Lo FS; Lin JL; Chao MC; Hsu CC; Ke YY; Chiu PC; Chen JC; Huang YH; Lin SP; Chou YY; Ting WH; Wang SY; Chiu CF; Huang YC; Hsiao HP; Lin CH; Wang CH; Bau DT; Lin CY
    In Vivo; 2024; 38(1):341-350. PubMed ID: 38148081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking FGF23 signaling improves the growth plate of mice with X-linked hypophosphatemia.
    Fuente R; Pastor-Arroyo EM; Gehring N; Oro Carbajosa P; Alonso-Durán L; Zderic I; Tapia-Dean J; Hamid AK; Bettoni C; Santos F; Wagner CA; Rubio-Aliaga I
    J Endocrinol; 2023 Sep; 259(1):. PubMed ID: 37439399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic role of Fgf23 in Dmp1-null mice.
    Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH.
    Liu ES; Thoonen R; Petit E; Yu B; Buys ES; Scherrer-Crosbie M; Demay MB
    Endocrinology; 2018 May; 159(5):2165-2172. PubMed ID: 29635291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF23 and its role in X-linked hypophosphatemia-related morbidity.
    Beck-Nielsen SS; Mughal Z; Haffner D; Nilsson O; Levtchenko E; Ariceta G; de Lucas Collantes C; Schnabel D; Jandhyala R; Mäkitie O
    Orphanet J Rare Dis; 2019 Feb; 14(1):58. PubMed ID: 30808384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of calcimimetic R568 and calcitriol in mineral homeostasis in the Hyp mouse, a murine homolog of X-linked hypophosphatemia.
    Leifheit-Nestler M; Kucka J; Yoshizawa E; Behets G; D'Haese P; Bergen C; Meier M; Fischer DC; Haffner D
    Bone; 2017 Oct; 103():224-232. PubMed ID: 28728941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and Molecular Alterations Underlying Abnormal Bone Growth in X-Linked Hypophosphatemia.
    Fuente R; García-Bengoa M; Fernández-Iglesias Á; Gil-Peña H; Santos F; López JM
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
    Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG
    PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A PAI-1 antagonist ameliorates hypophosphatemia in the Hyp vitamin D-resistant rickets model mouse.
    Qian C; Ito N; Tsuji K; Sato S; Kikuchi K; Yoshii T; Miyata T; Asou Y
    FEBS Open Bio; 2024 Feb; 14(2):290-299. PubMed ID: 38050660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia.
    Aono Y; Yamazaki Y; Yasutake J; Kawata T; Hasegawa H; Urakawa I; Fujita T; Wada M; Yamashita T; Fukumoto S; Shimada T
    J Bone Miner Res; 2009 Nov; 24(11):1879-88. PubMed ID: 19419316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital Conditions of Hypophosphatemia Expressed in Adults.
    Marcucci G; Brandi ML
    Calcif Tissue Int; 2021 Jan; 108(1):91-103. PubMed ID: 32409880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.